National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 44166 [07-3847]
Download as PDF
<![CDATA[
44166
Federal Register / Vol. 72, No. 151 / Tuesday, August 7, 2007 / Notices
TABLE 2.—ANNUALIZED COST TO RESPONDENTS
Number of
respondents
Type of respondents
Response frequency
Approx. hourly
wage rate
Total respondent cost**
Applicants ........................................................................................................
Extramural evaluators ......................................................................................
1200
220
1
1
$55.00
55.00
$8,250
1,512.50
Total ..........................................................................................................
710
1
55.00
9,662.50
**Total Respondent Cost = N Respondents * Response Frequency * minutes to complete/60 * hourly rate.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact G. Stephane
Philogene, PhD, Assistant Director for
Policy and Planning, Office of
Behavioral and Social Sciences
Research, National Institutes of Health,
31 Center Drive. Building 31, Room B2–
B37 Bethesda, MD 20892, or call nontoll-free number 301–402–3902, or Email your request, including your
address to: philoges@od.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT:
Dated: July 31, 2007.
G. Stephane Philogene,
Assistant Director for Policy and Planning,
Office of Behavioral and Social Sciences
Research, National Institutes of Health.
[FR Doc. E7–15350 Filed 8–6–07; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 4140–01–P
VerDate Aug<31>2005
15:56 Aug 06, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Establishment
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Director, National
Institutes of Health (NIH), announces
the establishment of the Interagency
Autism Coordinating Committee
(Committee).
The Committee shall coordinate all
efforts within the Department of Health
and Human Services concerning autism
spectrum disorder to combat autism
through research, screening,
intervention and education. The
Committee’s primary mission is to
facilitate the efficient and effective
exchange of information on autism
activities among the member agencies,
and to coordinate autism-related
programs and initiatives. The
Committee will serve as a forum and
assist in increasing public
understanding of the member agencies’
activities, programs, policies, and
research, and in bringing important
matters of interest forward for
discussion.
Duration of this committee is two
years from the date the Charter is filed.
Dated: July 31, 2007.
Elias Zerhouni,
Director, National Institutes of Health.
[FR Doc. 07–3850 Filed 8–6–07; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Weight Control Clinical Trial.
Date: September 14, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Dr., Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Youngsuk Oh, Scientific
Review Administrator, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7182,
Bethesda, MD 20892–7924, 301–435–0277,
yoh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–3847 Filed 8–6–07; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Diabetes and Digestive and
Kidney Diseases Advisory Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
E:\FR\FM\07AUN1.SGM
07AUN1
]]>Agencies
[Federal Register Volume 72, Number 151 (Tuesday, August 7, 2007)]
[Notices]
[Page 44166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3847]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Weight Control Clinical Trial.
Date: September 14, 2007.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Dr.,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Youngsuk Oh, Scientific Review Administrator,
Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701
Rockledge Drive, Room 7182, Bethesda, MD 20892-7924, 301-435-0277,
yoh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: July 31, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-3847 Filed 8-6-07; 8:45 am]
BILLING CODE 4140-01-M
